Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 Penumbra Inc at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023 / 01:00PM GMT
Release Date Price:
€224
(-1.75%)
William John Plovanic
Canaccord Genuity Corp., Research Division - MD of Life Science Research
Great. Good morning. Thank you for joining us at Canaccord's 43rd Annual Global Growth Conference. I am Bill Plovanic, one of the Canaccord senior medical device analysts. We're excited to host Penumbra. And with us today is Jason Mills, EVP of Strategy. Thanks for joining us today, Jason.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Thank you.
William John Plovanic
Canaccord Genuity Corp., Research Division - MD of Life Science Research
And just a reminder, the format today is a brief overview presentation followed by a fireside -- the format today is a brief overview presentation followed by a fireside chat Q&A session. And with that, I'd like to hand it over to Jason.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Thanks, Bill. I think I'm mic-ed up, so maybe I'll be able to hear without these microphones. Thank you very much. My name is Jason Mills. As
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot